“Dupilumab Improves Patient-Reported Outcomes As Early As 1 Month Among Adults With Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s506. Accessed May 19, 2025. https://skin.dermsquared.com/skin/article/view/3076.